Affiliation:
1. 国立研究開発法人産業技術総合研究所健康医工学研究部門
2. 札幌保健医療大学保健医療学部看護学科
Publisher
Japanese Society on Thrombosis and Hemostasis
Reference23 articles.
1. 1) Connolly SJ, Ezekowitz MD, Yusuf S, et al.: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361: 1139–1151, 2009.
2. 2) Patel MR, Mahaffey KW, Garg J, et al.; ROCKET AF Investigators: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365: 883–891, 2011.
3. 3) Granger CB, Alexander JH, McMurray JJ, et al.; ARISTOTLE Committees and Investigators: Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365: 981–992, 2011.
4. 4) Giugliano RP, Ruff CT, Braunwald E, et al.: Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369: 2093–2104, 2013.
5. 5) Wang YP, Kehar R, Iansavitchene A, et al.: Bleeding risk in nonvalvular atrial fibrillation patients receiving direct oral anticoagulants and warfarin: A systematic review and meta-analysis of observational studies. TH Open 4: e145–e152, 2020.